Thiopurine treatment in patients with Crohn's disease leads to a selective reduction of an effector cytotoxic gene expression signature revealed by whole-genome expression profiling

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)472-481
JournalMolecular Immunology
Volume54
Issue number3-4
DOIs
Publication statusPublished - 2013

Cite this